BTG plc acquires, develops, manufactures, and commercializes pharmaceutical products in the United States, Europe, and internationally. It operates through three segments: Interventional Medicine, Pharmaceuticals, and Licensing. The Interventional Medicine segment offers interventional oncology products and systems, such as beads and TheraSphere for treatment of liver cancer; and GALIL medical system, a cryoablation technology for use in kidney cancer and other indications.
Read More…
Industry, Sector and Symbol
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone+44-20-75750000
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales£914.10 million
Profitability
Miscellaneous
Employees1,631
Next Earnings DateN/A
OptionableOptionable
BTG (LON:BTG) Frequently Asked Questions
What is BTG's stock symbol?
BTG trades on the London Stock Exchange (LON) under the ticker symbol "BTG."
How were BTG's earnings last quarter?
BTG plc (LON:BTG) announced its quarterly earnings data on Tuesday, May, 15th. The company reported $32.90 EPS for the quarter, beating the Zacks' consensus estimate of $29.80 by $3.10. View BTG's Earnings History.
What price target have analysts set for BTG?
2 analysts have issued twelve-month target prices for BTG's shares. Their forecasts range from GBX 840 to GBX 840. On average, they expect BTG's stock price to reach GBX 840 in the next year. View Analyst Price Targets for BTG.
What is the consensus analysts' recommendation for BTG?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for BTG in the last year. There are currently 1 sell rating and 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for BTG.
Has BTG been receiving favorable news coverage?
News articles about BTG stock have trended somewhat positive this week, according to InfoTrie. InfoTrie identifies negative and positive news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. BTG earned a coverage optimism score of 1.5 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for BTG.
Who are some of BTG's key competitors?
Some companies that are related to BTG include MorphoSys (MOR), MorphoSys (MOR), Cronos Group (CRON), Asterias Biotherapeutics (AST), Abcam (ABC), Genus (GNS), Polynovo (PNV), Clinuvel Pharmaceuticals (CUV), Vir Biotechnology (VIR), Concordia International (CXR), Kodiak Sciences (KOD), Immutep (IMM), Mesoblast (MSB), Paradigm Biopharmaceuticals (PAR) and Starpharma (SPL).
What other stocks do shareholders of BTG own?
Who are BTG's key executives?
BTG's management team includes the folowing people:
- Dr. Louise Makin MA, Ph.D.(Cantab), MBA, DBE, CEO & Exec. Director (Age 58)
- Mr. Duncan Kennedy A.C.A., B.Sc., CFO & Director
- Dr. Peter Stratford, Chief Technical Officer & Head of Innovation (Age 52)
- Mr. Andy Burrows, VP of Corp. & Investor Relations
- Dr. Paul Mussenden, Gen. Counsel, Head of Strategic Affairs & Company Sec.
How do I buy shares of BTG?
Shares of BTG and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
How big of a company is BTG?
What is BTG's official website?
How can I contact BTG?
BTG's mailing address is 5 Fleet Place, LONDON, EC4M 7RD, United Kingdom. The company can be reached via phone at +44-20-75750000.
MarketBeat Community Rating for BTG (LON BTG)
MarketBeat's community ratings are surveys of what our community members think about BTG and other stocks. Vote "Outperform" if you believe BTG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BTG will underperform the S&P 500 over the long term. You may vote once every thirty days.
